Drug and Therapeutics Bulletin 2009;47:19-21; doi:10.1136/dtb.2009.01.0002
Copyright © 2009 by the BMJ Publishing Group Ltd.
Oral or intramuscular vitamin B12?
Relevant BNF section: 9.1.2
Vitamin B12 deficiency is common, becoming more so with age, and estimates of its population prevalence have ranged from 1.5% to 15%.1,2 If untreated, it can lead to megaloblastic anaemia and irreversible neurological complications. In the UK, the usual treatment is regular intramuscular injections of hydroxocobalamin.3,4 High-dose oral vitamin B12 replacement is standard practice in some other countries5 and less costly.6 Here we review issues around adopting an oral vitamin B12 replacement regimen more widely in the UK.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
- Full Text
- Full Text (PDF)
- A correction has been published
- Submit a response
- Alert me when this article is cited
- Alert me when eLetters are posted
- Alert me if a correction is posted
Services
- Email this link to a friend
- Similar articles in this journal
- Similar articles in PubMed
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with
Register for email alerts
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
Coming soon!
The DTB archive back to 1962, volume 1, issue 1 will soon be available.
